Analysts Expect Masimo Corporation (MASI) Will Post Quarterly Sales of $201.63 Million
Analysts expect that Masimo Corporation (NASDAQ:MASI) will post $201.63 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for Masimo Corporation’s earnings, with the highest sales estimate coming in at $202.20 million and the lowest estimate coming in at $201.33 million. Masimo Corporation posted sales of $183.20 million during the same quarter last year, which would indicate a positive year over year growth rate of 10.1%. The business is scheduled to report its next quarterly earnings report on Tuesday, February 13th.
According to Zacks, analysts expect that Masimo Corporation will report full year sales of $201.63 million for the current year, with estimates ranging from $774.25 million to $775.10 million. For the next financial year, analysts forecast that the business will report sales of $828.13 million per share, with estimates ranging from $810.90 million to $837.85 million. Zacks’ sales calculations are an average based on a survey of research firms that cover Masimo Corporation.
Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. The company had revenue of $193.69 million for the quarter, compared to the consensus estimate of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. The company’s quarterly revenue was up 15.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.52 earnings per share.
A number of research firms have recently issued reports on MASI. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Monday, August 14th. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 target price on shares of Masimo Corporation in a research note on Friday, November 3rd. Finally, Zacks Investment Research upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $97.17.
Masimo Corporation (NASDAQ:MASI) traded up $0.12 during trading hours on Friday, hitting $86.49. 478,200 shares of the stock were exchanged, compared to its average volume of 628,093. Masimo Corporation has a 52 week low of $60.31 and a 52 week high of $104.71. The company has a market capitalization of $4,470.00, a PE ratio of 33.09, a P/E/G ratio of 2.91 and a beta of 0.74.
ILLEGAL ACTIVITY WARNING: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/11/17/analysts-expect-masimo-corporation-masi-will-post-quarterly-sales-of-201-63-million.html.
In other Masimo Corporation news, EVP Yongsam Lee sold 5,000 shares of Masimo Corporation stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $89.89, for a total transaction of $449,450.00. Following the completion of the sale, the executive vice president now owns 74,000 shares of the company’s stock, valued at approximately $6,651,860. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Steven Barker sold 10,000 shares of Masimo Corporation stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the sale, the director now directly owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The disclosure for this sale can be found here. Insiders sold a total of 28,976 shares of company stock valued at $2,599,324 in the last 90 days. 16.60% of the stock is currently owned by corporate insiders.
Several hedge funds have recently made changes to their positions in MASI. Bank of Montreal Can grew its holdings in shares of Masimo Corporation by 126.1% in the 2nd quarter. Bank of Montreal Can now owns 110,694 shares of the medical equipment provider’s stock valued at $10,093,000 after buying an additional 61,736 shares during the period. NN Investment Partners Holdings N.V. acquired a new position in shares of Masimo Corporation in the 2nd quarter valued at $785,000. Oregon Public Employees Retirement Fund grew its holdings in shares of Masimo Corporation by 4.6% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 16,744 shares of the medical equipment provider’s stock valued at $1,527,000 after buying an additional 733 shares during the period. LS Investment Advisors LLC grew its holdings in shares of Masimo Corporation by 13.5% in the 2nd quarter. LS Investment Advisors LLC now owns 5,205 shares of the medical equipment provider’s stock valued at $475,000 after buying an additional 620 shares during the period. Finally, Louisiana State Employees Retirement System grew its holdings in shares of Masimo Corporation by 5.3% in the 2nd quarter. Louisiana State Employees Retirement System now owns 11,900 shares of the medical equipment provider’s stock valued at $1,085,000 after buying an additional 600 shares during the period. 84.94% of the stock is owned by institutional investors.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.